Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Goldman Sachs Downgrades Comstock Res to Sell

Goldman Sachs analyst Umang Choudhary downgrades Comstock Res (NYSE:CRK) from Neutral to Sell.

byBenzinga Newsdesk

July 18, 2022

1 minute read

Goldman Sachs analyst Umang Choudhary downgrades Comstock Res (NYSE:CRK) from Neutral to Sell.

FDA
News

Pfizer To Invest $120M To Produce Covid-19 Oral Treatment In The U.S.

By Benzinga Newsdesk

June 6, 11:01 AM

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. Expansion will create more than 250 additional high-skilled manufacturing jobs at Pfizer's Kalamazoo site Pfizer Inc. (NYSE:PFE)

PFE

Inspirato Shares Soar More Than 500%: What’s Going On?

By Adam Eckert

February 17, 4:49 PM

Inspirato Incorporated (NASDAQ: ISPO) is soaring more than 500% Thursday, just a few days after the company completed its SPAC merger with Thayer Ventures. The move appears to be related to the high number of investors who opted to redeem shares during the merger process.

ISPO

Wedbush Downgrades D.R. Horton to Neutral, Lowers Price Target to $96

By Benzinga Newsdesk

January 25, 8:11 AM

Wedbush analyst Jay McCanless downgrades D.R. Horton (NYSE:DHI) from Outperform to Neutral and lowers the price target from $104 to $96.

DHI

Cloopen Plans $40M Share Buyback Plan

By Anusuya Lahiri

September 28, 7:45 AM

Cloud-based communications solution provider Cloopen Group Holding Ltd’s (NYSE:RAAS) board approved a share repurchase program of up to $40 million of its…

RAAS

Goldman Sachs Downgrades Comstock Res to Sell

Related Posts

Pfizer To Invest $120M To Produce Covid-19 Oral Treatment In The U.S.

Inspirato Shares Soar More Than 500%: What’s Going On?

Wedbush Downgrades D.R. Horton to Neutral, Lowers Price Target to $96

Cloopen Plans $40M Share Buyback Plan